Panchal Rekha G, Ruthel Gordon, Kenny Tara A, Kallstrom George H, Lane Douglas, Badie Shirin S, Li Limin, Bavari Sina, Aman M Javad
Developmental Therapeutics Program, Target Structure Based Drug Discovery Group, Science Applications International Corporation, National Cancer Institute, Frederick, MD 21702-1201, USA.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15936-41. doi: 10.1073/pnas.2533915100. Epub 2003 Dec 12.
The matrix protein VP40 plays a critical role in Ebola virus assembly and budding, a process that utilizes specialized membrane domains known as lipid rafts. Previous studies with purified protein suggest a role for oligomerization of VP40 in this process. Here, we demonstrate VP40 oligomers in lipid rafts of mammalian cells, virus-like particles, and in the authentic Ebola virus. By mutagenesis, we identify several critical C-terminal sequences that regulate oligomerization at the plasma membrane, association with detergent-resistant membranes, and vesicular release of VP40, directly linking these phenomena. Furthermore, we demonstrate the active recruitment of TSG101 into lipid rafts by VP40. We also report the successful application of the biarsenic fluorophore, FlAsH, combined with a tetracysteine tag for imaging of Ebola VP40 in live cells.
基质蛋白VP40在埃博拉病毒的组装和出芽过程中起着关键作用,这一过程利用了称为脂筏的特殊膜结构域。先前对纯化蛋白的研究表明VP40寡聚化在此过程中发挥作用。在这里,我们在哺乳动物细胞的脂筏、病毒样颗粒和真实的埃博拉病毒中证实了VP40寡聚体的存在。通过诱变,我们鉴定出几个关键的C末端序列,它们调节质膜上的寡聚化、与抗去污剂膜的结合以及VP40的囊泡释放,直接将这些现象联系起来。此外,我们证明了VP40能将TSG101主动招募到脂筏中。我们还报告了双砷荧光团FlAsH与四半胱氨酸标签结合在活细胞中对埃博拉病毒VP40进行成像的成功应用。